Bath & Body Works (NYSE:BBWI) Given New $41.00 Price Target at JPMorgan Chase & Co.

Bath & Body Works (NYSE:BBWI) had its target price raised by JPMorgan Chase & Co. from $39.00 to $41.00 in a research report report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock.

BBWI has been the subject of a number of other research reports. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $42.00 price target on shares of Bath & Body Works in a research note on Monday, November 25th. Deutsche Bank Aktiengesellschaft raised their price target on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Morgan Stanley dropped their price target on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research note on Thursday, November 21st. Wells Fargo & Company raised Bath & Body Works from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $42.00 to $48.00 in a research note on Friday, January 10th. Finally, TD Cowen raised their price target on Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and a consensus price target of $43.19.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $36.98 on Friday. Bath & Body Works has a 52-week low of $26.20 and a 52-week high of $52.99. The stock has a market capitalization of $8.01 billion, a price-to-earnings ratio of 9.02, a P/E/G ratio of 1.01 and a beta of 1.82. The company’s 50 day moving average price is $36.86 and its 200-day moving average price is $33.66.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter last year, the business earned $0.48 earnings per share. The business’s revenue was up 3.1% on a year-over-year basis. As a group, equities research analysts forecast that Bath & Body Works will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were issued a dividend of $0.20 per share. The ex-dividend date was Friday, November 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.16%. Bath & Body Works’s payout ratio is presently 19.51%.

Hedge Funds Weigh In On Bath & Body Works

Several institutional investors and hedge funds have recently modified their holdings of BBWI. FMR LLC increased its holdings in shares of Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock valued at $80,315,000 after acquiring an additional 2,501,828 shares in the last quarter. KBC Group NV increased its holdings in Bath & Body Works by 9,023.5% in the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after buying an additional 1,683,160 shares in the last quarter. Erste Asset Management GmbH bought a new stake in Bath & Body Works in the 3rd quarter worth about $50,483,000. Assenagon Asset Management S.A. increased its holdings in Bath & Body Works by 723.4% in the 3rd quarter. Assenagon Asset Management S.A. now owns 1,167,554 shares of the company’s stock worth $37,268,000 after buying an additional 1,025,757 shares in the last quarter. Finally, Senvest Management LLC bought a new stake in Bath & Body Works in the 3rd quarter worth about $30,537,000. 95.14% of the stock is currently owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.